> top > docs > PubMed:10807385 > annotations

PubMed:10807385 JSONTXT

Annnotations TAB JSON ListView MergeView

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 96-111 HP_0100615 denotes ovarian cancers
T2 104-111 HP_0002664 denotes cancers
T3 242-256 HP_0100615 denotes ovarian cancer
T4 250-256 HP_0002664 denotes cancer

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
10807385-1#74#79#gene672 2268-2543 gene672 denotes BRCA-associated hereditary ovarian cancers in this population have surgical and pathological characteristics similar to those of sporadic cancers, advanced-stage hereditary cancer patients survive longer than nonhereditary cancer patients. Age penetrance is greater for BRCA1
10807385-1#83#88#gene675 2560-2565 gene675 denotes BRCA2
10807385-1#16#31#diseaseC0029925 1471-1682 diseaseC0029925 denotes or advanced-stage (II and IV) cases. RESULTS: Hereditary cancers were rarely diagnosed before age 40 years and were common after age 60 years, with mean age at diagnosis being significantly younger for BRCA1- vs
10807385-1#16#31#diseaseC1140680 1471-1682 diseaseC1140680 denotes or advanced-stage (II and IV) cases. RESULTS: Hereditary cancers were rarely diagnosed before age 40 years and were common after age 60 years, with mean age at diagnosis being significantly younger for BRCA1- vs
10807385-1#16#31#diseaseC0029925 1471-1682 diseaseC0029925 denotes or advanced-stage (II and IV) cases. RESULTS: Hereditary cancers were rarely diagnosed before age 40 years and were common after age 60 years, with mean age at diagnosis being significantly younger for BRCA1- vs
10807385-1#16#31#diseaseC1140680 1471-1682 diseaseC1140680 denotes or advanced-stage (II and IV) cases. RESULTS: Hereditary cancers were rarely diagnosed before age 40 years and were common after age 60 years, with mean age at diagnosis being significantly younger for BRCA1- vs
74#79#gene67216#31#diseaseC0029925 10807385-1#74#79#gene672 10807385-1#16#31#diseaseC0029925 associated_with "BRCA-associated hereditary ovarian cancers in this population have surgical and pathological characteristics similar to those of sporadic cancers, advanced-stage hereditary cancer patients survive longer than nonhereditary cancer patients. Age penetrance is greater for BRCA1","or advanced-stage (II and IV) cases. RESULTS: Hereditary cancers were rarely diagnosed before age 40 years and were common after age 60 years, with mean age at diagnosis being significantly younger for BRCA1- vs"
74#79#gene67216#31#diseaseC1140680 10807385-1#74#79#gene672 10807385-1#16#31#diseaseC1140680 associated_with "BRCA-associated hereditary ovarian cancers in this population have surgical and pathological characteristics similar to those of sporadic cancers, advanced-stage hereditary cancer patients survive longer than nonhereditary cancer patients. Age penetrance is greater for BRCA1","or advanced-stage (II and IV) cases. RESULTS: Hereditary cancers were rarely diagnosed before age 40 years and were common after age 60 years, with mean age at diagnosis being significantly younger for BRCA1- vs"
74#79#gene67216#31#diseaseC0029925 10807385-1#74#79#gene672 10807385-1#16#31#diseaseC0029925 associated_with "BRCA-associated hereditary ovarian cancers in this population have surgical and pathological characteristics similar to those of sporadic cancers, advanced-stage hereditary cancer patients survive longer than nonhereditary cancer patients. Age penetrance is greater for BRCA1","or advanced-stage (II and IV) cases. RESULTS: Hereditary cancers were rarely diagnosed before age 40 years and were common after age 60 years, with mean age at diagnosis being significantly younger for BRCA1- vs"
74#79#gene67216#31#diseaseC1140680 10807385-1#74#79#gene672 10807385-1#16#31#diseaseC1140680 associated_with "BRCA-associated hereditary ovarian cancers in this population have surgical and pathological characteristics similar to those of sporadic cancers, advanced-stage hereditary cancer patients survive longer than nonhereditary cancer patients. Age penetrance is greater for BRCA1","or advanced-stage (II and IV) cases. RESULTS: Hereditary cancers were rarely diagnosed before age 40 years and were common after age 60 years, with mean age at diagnosis being significantly younger for BRCA1- vs"
83#88#gene67516#31#diseaseC0029925 10807385-1#83#88#gene675 10807385-1#16#31#diseaseC0029925 associated_with BRCA2,"or advanced-stage (II and IV) cases. RESULTS: Hereditary cancers were rarely diagnosed before age 40 years and were common after age 60 years, with mean age at diagnosis being significantly younger for BRCA1- vs"
83#88#gene67516#31#diseaseC1140680 10807385-1#83#88#gene675 10807385-1#16#31#diseaseC1140680 associated_with BRCA2,"or advanced-stage (II and IV) cases. RESULTS: Hereditary cancers were rarely diagnosed before age 40 years and were common after age 60 years, with mean age at diagnosis being significantly younger for BRCA1- vs"
83#88#gene67516#31#diseaseC0029925 10807385-1#83#88#gene675 10807385-1#16#31#diseaseC0029925 associated_with BRCA2,"or advanced-stage (II and IV) cases. RESULTS: Hereditary cancers were rarely diagnosed before age 40 years and were common after age 60 years, with mean age at diagnosis being significantly younger for BRCA1- vs"
83#88#gene67516#31#diseaseC1140680 10807385-1#83#88#gene675 10807385-1#16#31#diseaseC1140680 associated_with BRCA2,"or advanced-stage (II and IV) cases. RESULTS: Hereditary cancers were rarely diagnosed before age 40 years and were common after age 60 years, with mean age at diagnosis being significantly younger for BRCA1- vs"

NCBIDiseaseCorpus

Id Subject Object Predicate Lexical cue
T1 30-69 CompositeMention:OMIM:604370|OMIM:612555|OMIM:613399|D010051 denotes BRCA-linked and sporadic ovarian cancer
T2 85-111 SpecificDisease:D061325 denotes hereditary ovarian cancers
T3 242-256 SpecificDisease:D010051 denotes ovarian cancer
T4 355-381 SpecificDisease:D061325 denotes hereditary ovarian cancers
T5 445-485 SpecificDisease:D010051 denotes sporadic (nonhereditary) ovarian cancers
T6 565-580 SpecificDisease:D010051 denotes ovarian cancers
T7 648-654 Modifier:D009369 denotes cancer
T8 692-698 Modifier:D009369 denotes Cancer
T9 1223-1237 SpecificDisease:D010051 denotes ovarian cancer
T10 1517-1535 DiseaseClass:D009369 denotes Hereditary cancers
T11 2065-2083 DiseaseClass:D009369 denotes hereditary cancers
T12 2158-2175 DiseaseClass:D009369 denotes stage III cancers
T13 2268-2310 SpecificDisease:OMIM:604370|OMIM:612555|OMIM:613399 denotes BRCA-associated hereditary ovarian cancers
T14 2397-2413 DiseaseClass:D009369 denotes sporadic cancers
T15 2415-2447 Modifier:D009386 denotes advanced-stage hereditary cancer
T16 2477-2497 Modifier:D009369 denotes nonhereditary cancer
T17 2538-2580 CompositeMention:OMIM:604370|OMIM:612555 denotes BRCA1-linked than for BRCA2-linked cancers

DisGeNET

Id Subject Object Predicate Lexical cue
T0 2538-2543 gene:672 denotes BRCA1
T1 2573-2580 disease:C0006826 denotes cancers
T2 2560-2565 gene:675 denotes BRCA2
T3 2573-2580 disease:C0006826 denotes cancers
R1 T0 T1 associated_with BRCA1,cancers
R2 T2 T3 associated_with BRCA2,cancers

NCBI-Disease-Train

Id Subject Object Predicate Lexical cue database_id
T4554 30-69 CompositeMention denotes BRCA-linked and sporadic ovarian cancer OMIM:604370|OMIM:612555|OMIM:613399|D010051
T4555 85-111 SpecificDisease denotes hereditary ovarian cancers D061325
T4556 242-256 SpecificDisease denotes ovarian cancer D010051
T4557 355-381 SpecificDisease denotes hereditary ovarian cancers D061325
T4558 445-485 SpecificDisease denotes sporadic (nonhereditary) ovarian cancers D010051
T4559 565-580 SpecificDisease denotes ovarian cancers D010051
T4560 648-654 Modifier denotes cancer D009369
T4561 692-698 Modifier denotes Cancer D009369
T4562 1223-1237 SpecificDisease denotes ovarian cancer D010051
T4563 1517-1535 DiseaseClass denotes Hereditary cancers D009369
T4564 2065-2083 DiseaseClass denotes hereditary cancers D009369
T4565 2158-2175 DiseaseClass denotes stage III cancers D009369
T4566 2268-2310 SpecificDisease denotes BRCA-associated hereditary ovarian cancers OMIM:604370|OMIM:612555|OMIM:613399
T4567 2397-2413 DiseaseClass denotes sporadic cancers D009369
T4568 2415-2447 Modifier denotes advanced-stage hereditary cancer D009386
T4569 2477-2497 Modifier denotes nonhereditary cancer D009369
T4570 2538-2580 CompositeMention denotes BRCA1-linked than for BRCA2-linked cancers OMIM:604370|OMIM:612555

NCBI-Disease-Corpus-All

Id Subject Object Predicate Lexical cue database_id
T4554 30-69 CompositeMention denotes BRCA-linked and sporadic ovarian cancer OMIM:604370|OMIM:612555|OMIM:613399|D010051
T4555 85-111 SpecificDisease denotes hereditary ovarian cancers D061325
T4556 242-256 SpecificDisease denotes ovarian cancer D010051
T4557 355-381 SpecificDisease denotes hereditary ovarian cancers D061325
T4558 445-485 SpecificDisease denotes sporadic (nonhereditary) ovarian cancers D010051
T4559 565-580 SpecificDisease denotes ovarian cancers D010051
T4560 648-654 Modifier denotes cancer D009369
T4561 692-698 Modifier denotes Cancer D009369
T4562 1223-1237 SpecificDisease denotes ovarian cancer D010051
T4563 1517-1535 DiseaseClass denotes Hereditary cancers D009369
T4564 2065-2083 DiseaseClass denotes hereditary cancers D009369
T4565 2158-2175 DiseaseClass denotes stage III cancers D009369
T4566 2268-2310 SpecificDisease denotes BRCA-associated hereditary ovarian cancers OMIM:604370|OMIM:612555|OMIM:613399
T4567 2397-2413 DiseaseClass denotes sporadic cancers D009369
T4568 2415-2447 Modifier denotes advanced-stage hereditary cancer D009386
T4569 2477-2497 Modifier denotes nonhereditary cancer D009369
T4570 2538-2580 CompositeMention denotes BRCA1-linked than for BRCA2-linked cancers OMIM:604370|OMIM:612555

NCBI-Disease-Corpus-2stage-All

Id Subject Object Predicate Lexical cue
T1 55-69 SpecificDisease denotes ovarian cancer
T2 96-111 SpecificDisease denotes ovarian cancers
T3 242-256 SpecificDisease denotes ovarian cancer
T4 366-381 SpecificDisease denotes ovarian cancers
T5 470-485 SpecificDisease denotes ovarian cancers
T6 565-580 SpecificDisease denotes ovarian cancers
T7 1223-1237 SpecificDisease denotes ovarian cancer
T8 1528-1535 Modifier denotes cancers
T9 2076-2083 Modifier denotes cancers
T10 2168-2175 Modifier denotes cancers
T11 2295-2310 Modifier denotes ovarian cancers
T12 2406-2413 Modifier denotes cancers
T13 2441-2447 Modifier denotes cancer
T14 2491-2506 Modifier denotes cancer patients
T15 2573-2580 Modifier denotes cancers

NCBI-Disease-Corpus-rezarta-All

Id Subject Object Predicate Lexical cue
T1 55-69 SpecificDisease denotes ovarian cancer
T2 96-111 Modifier denotes ovarian cancers
T3 242-256 SpecificDisease denotes ovarian cancer
T4 366-381 Modifier denotes ovarian cancers
T5 470-485 Modifier denotes ovarian cancers
T6 565-580 SpecificDisease denotes ovarian cancers
T7 1223-1237 SpecificDisease denotes ovarian cancer
T8 2295-2310 Modifier denotes ovarian cancers
T9 2573-2580 Modifier denotes cancers

NCBI-Disease-Corpus-4oGuideline-All

Id Subject Object Predicate Lexical cue
T1 55-69 SpecificDisease denotes ovarian cancer
T2 96-111 SpecificDisease denotes ovarian cancers
T3 242-256 SpecificDisease denotes ovarian cancer
T4 366-381 SpecificDisease denotes ovarian cancers
T5 470-485 Modifier denotes ovarian cancers
T6 565-580 SpecificDisease denotes ovarian cancers
T7 648-654 SpecificDisease denotes cancer
T8 692-698 SpecificDisease denotes Cancer
T9 1223-1237 SpecificDisease denotes ovarian cancer
T10 1528-1535 SpecificDisease denotes cancers
T11 2076-2083 SpecificDisease denotes cancers
T12 2168-2175 SpecificDisease denotes cancers
T13 2295-2310 SpecificDisease denotes ovarian cancers
T14 2406-2413 Modifier denotes cancers
T15 2441-2447 SpecificDisease denotes cancer
T16 2491-2497 SpecificDisease denotes cancer
T17 2573-2580 SpecificDisease denotes cancers

NCBI-Disease-Corpus-Simple-All

Id Subject Object Predicate Lexical cue
T1 30-69 DiseaseClass denotes BRCA-linked and sporadic ovarian cancer
T2 96-111 DiseaseClass denotes ovarian cancers
T3 242-256 SpecificDisease denotes ovarian cancer
T4 355-381 DiseaseClass denotes hereditary ovarian cancers
T5 445-485 DiseaseClass denotes sporadic (nonhereditary) ovarian cancers
T6 565-580 SpecificDisease denotes ovarian cancers
T7 1223-1237 SpecificDisease denotes ovarian cancer
T8 1874-1886 Modifier denotes disease-free
T9 2158-2175 Modifier denotes stage III cancers
T10 2268-2310 DiseaseClass denotes BRCA-associated hereditary ovarian cancers
T11 2538-2550 CompositeMention denotes BRCA1-linked
T12 2560-2580 CompositeMention denotes BRCA2-linked cancers